Company Directory > Digital Health > GoodRx Holdings, Inc.
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of GoodRx Holdings, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
GoodRx is a leading American digital healthcare platform that provides consumers with tools to compare prescription drug prices and access negotiated discounts. The company operates a marketplace that aggregates pricing information from pharmacy benefit managers (PBMs) and pharmacies to help patients reduce out-of-pocket costs. Beyond its core price comparison tool, GoodRx has expanded into adjacencies including telehealth services, subscription-based savings programs (such as GoodRx Gold and the newly launched GoodRx Companion), and Pharma Direct solutions, which assist pharmaceutical manufacturers in reaching consumers with affordability programs.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:Prescription Price Transparency
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$765M-$785M
Founded:2011
Ownership:public
Status:operating
FUNDING
Total Raised:$22.2M
STOCK
Exchange:NASDAQ
Ticker:GDRX
0
CORPORATE STRUCTURE
Key Partnerships:Viatris (collaboration for brand medication savings), Pfizer (discount programs via branded storefront), Novo Nordisk (affordability initiatives)
COMPETITION
Position:Leader
Competitors:Hims & Hers Health, Amazon Pharmacy, Mark Cuban Cost Plus Drug Company
LEADERSHIP
Key Executives:
Wendy Barnes - CEO
Christopher McGinnis - CFO
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with GoodRx Holdings, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.